Allucent

Allucent is a global, full-service specialty contract research organization supporting small and mid-sized biotechnology and biopharmaceutical companies. Drawing on more than 30 years of regulatory, therapeutic, and operational experience, the company helps sponsors develop new treatments from preclinical planning through clinical trials, regulatory submission, and marketing approval. Its integrated services include clinical development strategy, study start-up and site feasibility, patient recruitment and retention, data management, biostatistics, medical monitoring, and clinical pharmacology.

Allucent also provides regulatory strategy and submissions, CMC and preclinical planning, GxP consulting, drug safety, and pharmacovigilance. Its quantitative expertise covers pharmacokinetics, pharmacodynamics, modeling and simulation, dose selection, and exposure-response analysis. Therapeutic experience spans oncology and hematology, infectious diseases and vaccines, neuroscience, immunology and inflammation, cardiometabolic disease, rare diseases, pediatrics, and cell and gene therapy.

Through global trial operations, regulatory guidance, and specialized scientific teams, Allucent aims to help clients address complex development challenges and advance potential therapies. The company reports experience across more than 75 countries and over 1,100 clinical trials